CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

NCT04891718 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Termination by pharmaceutical sponsor

Conditions

Solid Tumour

Interventions

BIOLOGICAL: MVC-101
BIOLOGICAL: Nivolumab
COMBINATION_PRODUCT: MVC-101 + Nivolumab

Sponsor

Presage Biosciences

Collaborators

[object Object]